Jump to content

Stock discussions


Vaampire

Recommended Posts

50 minutes ago, yemdoing said:

repati moves cheppandi va... friday kada paduthundhi antara ?

chusthunte repu kuda stocks anni kalisi kattuga ikyamatyam tho manalani 10ga pettala unayi

  • Haha 1
Link to comment
Share on other sites

1 hour ago, yemdoing said:

repati moves cheppandi va... friday kada paduthundhi antara ?

Calling @vampire  @pandemkodi

please can you give update of skillz .. what’s is the scope 

 

Link to comment
Share on other sites

1 hour ago, yemdoing said:

repati moves cheppandi va... friday kada paduthundhi antara ?

long weekend , expected a red day.. May be buying opportunities in good stocks. 

Link to comment
Share on other sites

3 hours ago, Simple123 said:

long weekend , expected a red day.. May be buying opportunities in good stocks. 

Agree could drop 

Link to comment
Share on other sites

19 minutes ago, macha said:

Anyone wants to gamble buy Tesla July 3rd week calls for 800 sp weekend q2 sales number will be released 

Never mind they just released 201k delivery …

Link to comment
Share on other sites

9 minutes ago, Simple123 said:

@Unityunity2  SKLZ is a buy at this price , it has support at $18 and will go to $24 and then $30.  I have SKLZ avg at $15.5 ,not selling for now.  Just hold if you have or buy below $20 if you don't have.

Thank you for info Bro

How should i should i recognize support at 18 $ or 24 $

Am holding at 20.17

Link to comment
Share on other sites

29 minutes ago, Simple123 said:

ITRM story entii ?  label ki approval ivvaleda or drug lo flaws unnaya ..  @MRI @AndhraneedSCS @Spartan  who ever bought ITRM ? please come for disco ? 

Can i buy  ITRM on this drop ?

I am sorry, I learned my lessons and won't trade Pharma and oil stocks.

 

Anyways, this was down as FDA found some deficiencies. 

 

  • Iterum Therapeutics (NASDAQ:ITRM) plummets 40% in after-hours trading after receiving FDA notification regarding NDA for sulopenem etzadroxil/probenecid.
  • The letter stated that, as part of the ongoing review, the Agency has identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments at this time.
  • No details with respect to deficiencies were disclosed.
Link to comment
Share on other sites

1 hour ago, AndhraneedSCS said:

I am sorry, I learned my lessons and won't trade Pharma and oil stocks.

 

Anyways, this was down as FDA found some deficiencies. 

 

  • Iterum Therapeutics (NASDAQ:ITRM) plummets 40% in after-hours trading after receiving FDA notification regarding NDA for sulopenem etzadroxil/probenecid.
  • The letter stated that, as part of the ongoing review, the Agency has identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments at this time.
  • No details with respect to deficiencies were disclosed.

lesson learned.. Nothing to feel bad..  So not looking into it.  Thank you.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...